Published in
Taylor and Francis Group, Scandinavian Journal of Gastroenterology, 2(56), p. 145-154, 2020
DOI: 10.1080/00365521.2020.1856405
Links
Tools
Efficacy of dashboard driven dosing of infliximab in inflammatory bowel disease patients; a randomized controlled trial
Journal article published in 2020 by
Anne S. Strik 
,
Mark Löwenberg,
Diane R. Mould ,
Sophie E. Berends ,
Cyriel I. Ponsioen,
Jan M. H. van den Brande,
Jeroen M. Jansen,
Daniël R. Hoekman,
Johannan F. Brandse,
Marjolijn Duijvestein,
Krisztina B. Gecse,
Annick de Vries,
Ron A. Mathôt ,
Geert R. D’Haens
,
Mark Löwenberg,
Diane R. Mould ,
Sophie E. Berends ,
Cyriel I. Ponsioen,
Jan M. H. van den Brande,
Jeroen M. Jansen,
Daniël R. Hoekman,
Johannan F. Brandse,
Marjolijn Duijvestein,
Krisztina B. Gecse,
Annick de Vries,
Ron A. Mathôt ,
Geert R. D’Haens
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 